Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4561 AL 4575

Low- vs. high-frequency deep brain stimulation in Parkinson's disease: A two-center double-blind crossover trial

Smeralda CL, De Monte D, Cinesi A, Giannotta A, Belgrado E, Bernardini A, Valente M, Lettieri C, Rossi S.

Brain Stimul. 2025 Nov-Dec;18(6):1741-1743. doi: 10.1016/j.brs.2025.09.006. Epub 2025 Sep 11.

Epigenetic mechanisms linking environmental exposure to Parkinson's disease: A comprehensive review

Singh H, Kumari S, Taliyan R.

Neuroscience. 2025 Oct 15;585:367-380. doi: 10.1016/j.neuroscience.2025.08.060. Epub 2025 Sep 11.

A Comparative Analysis of Psychiatric Symptoms in Parkinson's Disease Between Tremor-Dominant and Non-Tremor-Dominant Phenotypes

Akan M, Çıplak S, Adıgüzel A.

Neurol India. 2025 Sep 1;73(5):1012-1017. doi: 10.4103/neurol-india.Neurol-India-D-24-00415. Epub 2025 Sep 13.

Immunity in Parkinson's disease - the role of adaptive and auto-immune responses and gut-microbiome axis

Iyengar ARS, Dunkley PR, Dickson PW.

J Neuroimmunol. 2025 Dec 15;409:578755. doi: 10.1016/j.jneuroim.2025.578755. Epub 2025 Sep 10.

Moyamoya Disease and the Risk of Parkinson's Disease

Yoo D, Shin JY, Lee R, Cheon J, Kim JH, Kim D, Won JK, Oh IH, Lee Y, Ahn TB.

Ann Clin Transl Neurol. 2025 Dec;12(12):2523-2534. doi: 10.1002/acn3.70191. Epub 2025 Sep 14.

Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets

Wang H, Bi T, Yang W.

Acc Chem Res. 2025 Oct 7;58(19):3096-3110. doi: 10.1021/acs.accounts.5c00524. Epub 2025 Sep 14.

Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson's disease

Guo H, Shen X, Lyu M, Zhou G, Chen C, Xing B, Xie Y.

Front Neurol. 2025 Aug 29;16:1652378. doi: 10.3389/fneur.2025.1652378. eCollection 2025.

Peroxisomes as emerging clinical targets in neuroinflammatory diseases

Roczkowsky A, Rachubinski RA, Hobman TC, Power C.

Front Mol Neurosci. 2025 Aug 29;18:1642590. doi: 10.3389/fnmol.2025.1642590. eCollection 2025.

Wearable devices in neurological disorders: a narrative review of status quo and perspectives

Cai H, Hu J, Zhao C, Lin J.

Ann Transl Med. 2025 Aug 31;13(4):46. doi: 10.21037/atm-25-46. Epub 2025 Aug 26.

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report

Ahmed GU, Ahmed HU, Raza AA, Samadi A.

Case Rep Psychiatry. 2025 Sep 5;2025:8517387. doi: 10.1155/crps/8517387. eCollection 2025.

Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology

Webster JM, Yang YT, Miller AT, Zane A, Scholz K, Stone WJ, Mudium N, Corbin-Stein NJ, Won WJ, Stoll AC, Greathouse KM, Cooper NH, Long LF, Manuel PN, Herskowitz JH, Yacoubian TA, Tyrrell DJ, Sandoval IM, Manfredsson FP, Kordower JH, Harms AS.

bioRxiv [Preprint]. 2025 Nov 24:2024.10.13.618101. doi: 10.1101/2024.10.13.618101.

Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson's Disease Mutations

Lee YJ, Syed K, Busquets O, Li H, Dunnack J, Bateup HS, Soldner F, Hockemeyer D, Rio DC.

bioRxiv [Preprint]. 2025 Sep 4:2024.02.28.582420. doi: 10.1101/2024.02.28.582420.

Mitochondrial DNA damage in substantia nigra pars compacta astrocytes exacerbates dopaminergic neuron loss in a 6-hydroxydopamine mouse model of parkinsonism

Ayala DA, Hall GM, Tijerina E, Lopez L, Khan Z, Paliwal D, Anand A, Rimer M, Srinivasan R.

bioRxiv [Preprint]. 2025 Sep 3:2025.08.30.673287. doi: 10.1101/2025.08.30.673287.

Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders: a retrospective cohort study

Cahill J, Useinovic N, Toader A, Minns HE, Henn M, Lipson A, Cleary DR.

medRxiv [Preprint]. 2025 Sep 5:2025.09.03.25335065. doi: 10.1101/2025.09.03.25335065.

The LRRK2 p.A419V variant associates with risk of Parkinson's disease in the East Asian population and an evaluation on age of onset

Lim KS, Periñan MT, Chew EGY, Lee PS, Akçimen F, Lim JL, Koretsky MJ, Funayama M, Yoshino H, Hattori N, Kaiyrzhanov R, Houlden H, Isayan M, Tay YW, Toh TS, Lit LC, Khairul Anuar AN, Ding HX, Screven L, Mohamed Ibrahim N, Lin CH, Kim HJ, Lee JY, Chung SJ, Foo JN, Tan EK, Lim SY, Tan AH, Bandres-Ciga S, Ahmad-Annuar A; Global Parkinson’s Genetics Program (GP2).

medRxiv [Preprint]. 2025 Sep 2:2025.08.28.25333987. doi: 10.1101/2025.08.28.25333987.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias